We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
Cap. Flow
-$1.48B
Cap. Flow %
-3.4%
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$364M
2
SIVB
SVB Financial Group
SIVB
+$155M
3
TXT icon
Textron
TXT
+$103M
4
TWTR
Twitter, Inc.
TWTR
+$102M
5
SNY icon
Sanofi
SNY
+$96.4M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$333M
2
XOM icon
ExxonMobil
XOM
+$242M
3
DLTR icon
Dollar Tree
DLTR
+$231M
4
NTR icon
Nutrien
NTR
+$213M
5
EYE icon
National Vision
EYE
+$198M

Sector Composition

Rank Sector Weight
1 Technology 22.53%
2 Healthcare 17.73%
3 Financials 14.85%
4 Consumer Discretionary 9.35%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRAY icon
926
Dentsply Sirona
XRAY
$2.83B
$872K ﹤0.01%
24,400
-203,900
-89% -$8.25M
DNTH icon
927
Dianthus Therapeutics
DNTH
$5.8B
$847K ﹤0.01%
44,122
+19,879
+82% +$491K
PWR icon
928
Quanta Services
PWR
$102B
$839K ﹤0.01%
6,691
-142,100
-96% -$17.4M
RIGL icon
929
Rigel Pharmaceuticals
RIGL
$693M
$791K ﹤0.01%
70,000
-120,000
-63% -$2.41M
JBLU icon
930
JetBlue
JBLU
$2.35B
$774K ﹤0.01%
92,530
-1,840,000
-95% -$19.7M
SYRE icon
931
Spyre Therapeutics
SYRE
$8.24B
$758K ﹤0.01%
+60,000
New +$2.1M
HCIC
932
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$737K ﹤0.01%
75,000
– –
MOG.A icon
933
Moog Inc Class A
MOG.A
$12.5B
$600K ﹤0.01%
7,553
– –
SNV
934
DELISTED
Synovus
SNV
$560K ﹤0.01%
15,536
– –
GNLN icon
935
Greenlane Holdings
GNLN
$1.23M
– –
0
– –
VIST icon
936
Vista Energy
VIST
$7.5B
$491K ﹤0.01%
66,420
– –
EQOS
937
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$491K ﹤0.01%
585,988
-51,540
-8% -$68.7K
IMRX icon
938
Immuneering
IMRX
$270M
$460K ﹤0.01%
85,000
-65,000
-43% -$347K
LFUS icon
939
Littelfuse
LFUS
$11.3B
$457K ﹤0.01%
+1,800
New +$451K
ARWR icon
940
Arrowhead Research
ARWR
$12.1B
$454K ﹤0.01%
12,899
-10,700
-45% -$403K
MHK icon
941
Mohawk Industries
MHK
$9.01B
$443K ﹤0.01%
3,570
-54,900
-94% -$7.29M
CNDT icon
942
Conduent
CNDT
$268M
$436K ﹤0.01%
100,824
– –
WERN icon
943
Werner Enterprises
WERN
$2.23B
$411K ﹤0.01%
10,671
-80,000
-88% -$3.15M
EQRXW
944
DELISTED
EQRx, Inc. Warrant
EQRXW
$405K ﹤0.01%
500,000
– –
RAIN
945
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$380K ﹤0.01%
+68,282
New +$234K
PGSS.WS
946
DELISTED
Pegasus Digital Mobility Acquisition Corp. Redeemable Warrants
PGSS.WS
$372K ﹤0.01%
889,438
-10,562
-1% -$5.08K
HPP
947
Hudson Pacific Properties
HPP
$786M
$371K ﹤0.01%
+3,571
New +$528K
LRMR icon
948
Larimar Therapeutics
LRMR
$413M
$346K ﹤0.01%
176,680
– –
BSY icon
949
Bentley Systems
BSY
$10.9B
$333K ﹤0.01%
10,000
-20,000
-67% -$735K
CRHC.WS
950
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$287K ﹤0.01%
666,666
– –
36 37
38
39 40

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.

  • Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
  • Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
  • Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
  • Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
  • Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
  • Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.